Annexon Inc (ANNX) 13F Investor Activity Report (Q2 2026)

AI summary pending

Annexon (ticker: ANNX) said in its August 10, 2026 8-K that director Muneer Satter resigned from the board, the audit committee, and as chair of the nominating and corporate governance committee, effective just before Mark S. Blumenkranz, M.D., was appointed as his replacement; the company noted the resignation was not due to any disagreement with the company. Blumenkranz was appointed as a Class II director with a term running until the 2028 annual meeting, and will serve on the audit and science & technology committees. As a non-employee director, he receives a $40,000 annual retainer, an initial stock option for 175,000 shares, and an automatic 65,000-share option grant at each annual stockholder meeting. The filing also lists Items 7.01 and 9.01, but the excerpt provided does not include those details.

No AI summary for this filing type

Annexon entered into a loan and security agreement with Oxford Finance on July 30, 2026, for up to $200 million in term loans. The first $50 million was funded immediately; up to $100 million more is available if the company hits certain milestones, and an additional $50 million is available only if both sides agree. The money is for working capital and general corporate use. The loans carry a floating interest rate equal to the greater of 1-Month CME Term SOFR plus 4.6% or 7.60%, with maturity in 2031 or 2032 depending on milestones. Annexon pledged substantially all of its assets as collateral.